CLIPS

Welcome to the Brand page for “CLIPS”, which is offered here for Synthetic peptides for pharmaceutical purposes in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; synthetic peptides for the treatment of cancer, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders ; pharmaceutical preparations based on peptides in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; mimics consisting of peptides for antibodies;inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product development; pharmaceutical product evaluation; pharmaceutical research and development services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; identifying peptides in the nature of pharmaceutical research and development; optimalization of peptides and synthetic peptides in the nature of pharmaceutical research and development; research and development services in the field of synthetic peptides and other pharmaceutical preparations;.

Its status is currently believed to be active. Its class is unavailable. “CLIPS” is believed to be currently owned by “Biosynth B.V.”